Urinary Stents/Ureteral Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

Urinary Stents/Ureteral Stents Market By Product (Open-Ended, Close-Ended Double Pigtail, Double Loop Stent, And Others), By Material (Polymer, Metal, Polyurethane, Silicone, And Others) By Application (Kidney Stones, Inflammatory Bowel Disease, Tumors, And Others), By End-User (Hospitals, Ambulatory Surgical Centres, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of kidney diseases and the increasing prevalence of bladder cancer

The global urinary stents/ureteral stents market was valued at USD 433.08 million in 2023, growing at a CAGR of 6.01% during the forecast period from 2024 to 2030 to reach USD 612.87 million by 2030. The urinary stents/ureteral stents market is witnessing positive growth owing to various factors such as the increasing prevalence of kidney diseases, the increasing prevalence of bladder cancer, rise in the regulatory approvals for urinary stents/ureteral stents, and the rising prevalence of geriatric population across the globe. Therefore, the market for urinary stents/ureteral stents is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Urinary Stents/Ureteral Stents Market Dynamics:

One of the main drivers of the urinary stents/ureteral stents market is the increasing prevalence of kidney diseases globally such as kidney stones. For instance, according to the data from the Ministry of Health and Family Welfare (MoHFW), in the year 2023, kidney disorders afflicted around 195 million women globally. To treat such disorders urinary stents/ureteral stents are used, which allow urine to pass around a kidney stone that is obstructing urine flow and help patients to restore their renal function, this improves their clinical status significantly. Thus, owing to the surge in kidney disease cases, the use of urinary stents/ureteral stents could also increase, which can drive the overall urinary stents/ureteral stents market forward over the forecast period (2024-2030).

Moreover, another key factor that is driving the growth of the urinary stents/ureteral stents market is the increasing prevalence of bladder cancer across the globe. For instance, as per the GLOBOCAN data 2020, the worldwide cancer burden has increased to 19.3 million cases in the year 2020 and bladder cancer is the tenth most frequent cancer worldwide. According to the source mentioned above, 573,278 people worldwide were diagnosed with bladder cancer in the year 2020. The tumors in the bladder can obstruct specific routes that allow people to urinate, urinary stents/ureteral stents are inserted in the body to assist pee flow. Therefore, the increasing prevalence of bladder cancer boosts the demand for urinary stents/ureteral stents, which could surge the growth of the overall urinary stents/ureteral stents market during the forecast period from 2024-2030.

Therefore, the factors stated above collectively will drive the overall urinary stents/ureteral stents market during the forecast period from 2024-2030.

However, the high cost of ureteral stent placement and the adverse effects associated with ureteral stents such as bladder irritation, Urinary Tract Infections (UTI), and others, can hamper the global urinary stents/ureteral stents market growth.

The ongoing COVID-19 epidemic has negatively impacted the ureteral stents/urinary stents market. The nationwide lockdown in almost every country-restricted people's movement & hospital visits, halted supply chains & logistics, hampered the manufacturing process, resulting in a product shortage in the market, and elective surgeries were also halted and were not on priority because COVID-19 patients were given priority in terms of treatment. For instance, according to the American Hospital Association 2020, between March and June 2020, hospitals in the United States lost an estimated USD 50.7 billion owing to a decrease in "elective" treatments. According to the same research, these processes accounted for around 31% of net revenue in the United States on average. However, with the masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, manufacturing units, and an increase in elective surgeries, the ureteral stents/urinary stents market has picked momentum and is expected to further grow during the forecast period.

Urinary Stents/Ureteral Stents Market Segment Analysis:

Urinary Stents/Ureteral Stents Market by Product (Open-Ended, Close-Ended Double Pigtail, Double Loop Stent, and Others), Material (Polymer, Metal, Polyurethane, Silicone, and Others), Application (Kidney Stones, Inflammatory Bowel Disease, Tumors, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the urinary stents/ureteral stents market, due to kidney stones, the ureteral stents market is expected to have a significant revenue share in the year 2023, as kidney stone causes a blockage in the urinary tract. A ureteral stent is a soft, hollow tube that is inserted into the ureter for a short period, urine might drain through the stent. The coils on each end of the stent prevent it from moving, the coils at the top of the kidney and the coils at the bottom of the bladder. This relieves the discomfort caused by the blockage and allows the kidney to function normally again. Therefore, the benefits associated with urinary stents/ureteral stents for the treatment of kidney stones, increase the urinary stents/ureteral stents demand in the market, which could drive the growth of the overall global urinary stents/ureteral stents market during the forecast period.

However, various technologically advanced urinary stents/ureteral stents receive approvals, this is also expected to drive the overall market growth for urinary stents/ureteral stents. For instance, in April 2019, Boston Scientific Corporation, a manufacturer of medical devices, received Food and Drug Approval (FDA) for its Tria Firm ureteral Stent. The ureteral stent is designed to facilitate drainage from the kidney to the bladder by placing it endoscopically, fluoroscopically, or during an open surgical procedure by a trained physician.

Moreover, due to the interplay of all the factors mentioned above, this can result in the rising demand for urinary stents/ureteral stents, which in turn would provide a conducive growth environment for overall urinary stents/ureteral stents during the market forecast 2024-2030.

North America is expected to dominate the overall Urinary Stents/Ureteral Stents Market:

Among all the regions, North America is expected to dominate the global urinary stents/ureteral stents market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing prevalence of kidney diseases and the rise in the regulatory approvals for urinary stents/ureteral stents increase the demand for urinary stents/ureteral stents in the North America market.

According to the Centers for Disease Control and Prevention (CDC) published data in the year 2023, in the United States 37 million people are estimated to have Chronic Kidney Disease (CKD). Moreover, when kidney function is compromised by any disease or condition, chronic kidney disease develops. Over several months or years, the kidney damage gets worse. Furthermore, the ureters, a tube that allows urine to pass from the kidneys into the bladder, are kept open by ureteral stents. Ureteral stents are required for the conditions such as kidney stones, ureteral stones, constricted ureters, or tumors that block the ureter. Thus, due to the increasing prevalence of kidney diseases, urinary stents/ureteral stents demand can also increase, which could drive the overall urinary stents/ureteral stents market forward over the forecast period (2024-2030).

Furthermore, another factor such as the rise in the regulatory approvals for urinary stents/ureteral stents could drive the urinary stents/ureteral stents overall market in the region. For instance, in May 2022, the US FDA granted its 510k approval for a novel urinary stent developed by Dean Secrest and Lee Ponsky, MD, Chair of the Department of Urology and Leo & Charlotte Goldberg Chair in Advanced Surgical Therapies at University Hospitals (UH) in Cleveland. With the FDA's approval, the ReliefTM Stent can now be sold in the United States to people with kidney stones and other conditions that make it difficult for the kidney to drain urine.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the urinary stents/ureteral stents market.

Urinary Stents/Ureteral Stents Market Key Players:

Some of the key market players operating in the urinary stents/ureteral stents market include Allium Medical Solutions Ltd, Boston Scientific Corporation, B. Braun Melsungen AG, Cook, Coloplast Corp, BD, Medline Industries LP, Olympus America, Pnn Medical A/S, Teleflex Incorporated, Biomerics, UROMED Kurt Drews KG, TAEWOONG, Applied Medical Resources Corporation, GBUK Group Ltd, Dornier MedTech America Inc, Rocamed, HydrUStent SA, Blue Neem Medical Devices Pvt Ltd, ACE Medical Devices Pvt. Ltd and others

Recent Developmental Activities in the Urinary Stents/Ureteral Stents:

In April 2022, Boston Scientific Corporation received US FDA approval for its Percuflex(TM) Ureteral Stent System and PercufleXTM Ureteral Stent System Kit in the United States. The ureteral stent is designed to enable drainage from the ureteropelvic junction to the bladder and stenting of the ureter for those patients in whom it is preferable to implant a drain that does not extend externally

In June 2019, Merit Medical Systems Inc. which is a leading manufacturer and marketer of proprietary disposable medical devices acquired Brightwater Medical, which makes medical devices that focus on treatments for ureteral blockages by interventional radiologists, for a deal value of $35 million.

Key Takeaways from the Urinary Stents/Ureteral Stents Market Report Study

• Market size analysis for current urinary stents/ureteral stents market (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the urinary stents/ureteral stents market
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global urinary stents/ureteral stents
• Various opportunities are available for the other competitor in the urinary stents/ureteral stents market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current urinary stents/ureteral stents market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for urinary stents/ureteral stents market growth in the coming future?

Target Audience who can be benefited from this Urinary Stents/Ureteral Stents Market Report Study

• Urinary stents/ureteral stents providers
• Research organizations and consulting companies
• Urinary stents/ureteral stents-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in urinary stents/ureteral stents
• Various end-users who want to know more about the urinary stents/ureteral stents market and the latest technological developments in the urinary stents/ureteral stents

Frequently Asked Questions for Urinary Stents/Ureteral Stents:

1. What are Urinary Stents/Ureteral Stents?

Urinary stents/ureteral stents are thin tubes that are put into the ureter to prevent or cure renal urine flow restriction. The stents utilized in adult patients range in length from 24 to 30 cm.

2. What is the market for Global Urinary Stents/Ureteral Stents?

The global urinary stents/ureteral stents market was valued at USD 433.08 million in 2023, growing at a CAGR of 6.01% during the forecast period from 2024 to 2030 to reach USD 612.87 million by 2030.

3. What are the drivers for the Global Urinary Stents/Ureteral Stents market?

The urinary stents/ureteral stents market is witnessing a positive market growth owing to the factors such as the increasing prevalence kidney diseases, the increasing prevalence of bladder cancer, the rise in the regulatory approvals for urinary stents/ureteral stents, and the rising prevalence of geriatric population.

4. Who are the key players operating in the Urinary Stents/Ureteral Stents market?

Some of the key market players operating in the urinary stents/ureteral stents market include Allium Medical Solutions Ltd, Boston Scientific Corporation, B. Braun Melsungen AG, Cook, Coloplast Corp, BD, Medline Industries LP, Olympus America, Pnn Medical A/S, Teleflex Incorporated, Biomerics, UROMED Kurt Drews KG, TAEWOONG, Applied Medical Resources Corporation, GBUK Group Ltd, Dornier MedTech America Inc, Rocamed, HydrUStent SA, Blue Neem Medical Devices Pvt Ltd, ACE Medical Devices Pvt. Ltd and others

5. Which region has the highest share in Urinary Stents/Ureteral Stents Market?

North America is expected to dominate the global urinary stents/ureteral stents market. Factors contributing to the growth are the increasing prevalence of kidney diseases and the rise in the regulatory approvals for urinary stents/ureteral stents, which are contributing to the growth of the urinary stents/ureteral stents market in the North America region.